UCSF's Chancellor Hawgood urged transition to a "Second Curve" of innovation, leveraging philanthropy, new infrastructure, and AI to overcome funding challenges and ensure sustained excellence.

New testing in maternal hyperoxia — giving extra oxygen to pregnant people — shows that prenatal interventions might yield better outcomes for babies with congenital heart disease.

To address the specific challenges faced by older adults with inflammatory bowel disease (IBD), UCSF Health created the UCSF IBD Longevity Clinic to provide comprehensive and specialized care for patients aged 65 and older with this chronic condition.

Lee May, diagnosed with aggressive multiple myeloma at 59, defied odds with cutting-edge treatments at UCSF Health, including CAR-T therapy and NIH-funded innovations. Now 74 and in remission, May credits advanced research for his survival. UCSF leads the way in transforming blood cancer care.

Doctors have reduced opioid prescribing since the opioid epidemic’s peak, but a UCSF study found that this trend affects nursing home residents with chronic pain. An analysis of 3M residents saw declines in opioid use, with racial disparities in prescribing.

Neurologist Dr. Ptacek explains how "falling back" disrupts the 24-hour circadian clock, affecting mood and performance, with mitigation tips.

In a first, experts have created treatment guidelines and recommendations for women who experience low sexual desire or Hypoactive Sexual Desire Disorder (HSDD), a common yet largely undertreated issue experienced by women.

A study reveals how cigarette price sensitivity varies between U.S. adults who do and do not use cannabis. The findings could help shape tobacco tax policies to reduce cigarette use among cannabis users, offering key insights for effective tobacco control strategies.

UCSF researchers used AI to personalize Deep Brain Stimulation (DBS) for Parkinson's gait problems, leading to meaningful, customized improvements in walking and mobility—a major breakthrough for patients.

Martin Kampmann’s work, supported by the National Institutes of Health (NIH), maps cellular “decision points” that determine whether brain cells survive or die, laying the groundwork for treatments that intervene before irreversible brain damage occurs from dementia.